May 14, 2019
In re HIV Antitrust Litigation
Case Number:
3:19-cv-02573
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Kanner & Whiteley
- Kessler Topaz
- Dillingham & Murphy
- Holland & Knight
- Faegre Drinker
- Cahill Gordon
- Hilliard Shadowen
- Zelle LLP
- Lockridge Grindal
- Pritzker Levine
- Rivero Mestre
- NastLaw
- Kellogg Hansen
- Boies Schiller
- Spector Roseman
- Berry Silberberg
- White & Case
- Kirkland & Ellis
- Wiggin & Dana
- Roberts Law Firm US
- Morrison & Foerster
- Gibson Dunn
- Arnold & Porter
- Goodwin Procter
- Hagens Berman
- Polsinelli PC
- Frederick M. Lehrer Attorney at Law
- Ballard Spahr
- Robins Kaplan
- Troutman
- Duane Morris
- Nussbaum Law Group
- Wilson Sonsini
- Hausfeld LLP
- Law Offices of Francis O. Scarpulla
- Crowell & Moring
- Hangley Aronchick
- Milberg Coleman
- Gibbons PC
- Radice Law Firm
- Whatley Kallas
- Proskauer Rose
- Sperling Kenny
- Miller Shah
- Glancy Prongay
- Baron & Budd
Companies
- Johnson & Johnson
- Albertsons Cos. Inc.
- Fraternal Order of Police
- Humana Inc.
- Gilead Sciences Inc.
- Blue Cross Blue Shield Association
- BlueCross BlueShield of South Carolina
- MSP Recovery
- Service Employees International Union
- Amneal Pharmaceuticals Inc.
- Health Care Service Corp.
- Akros Pharma Inc.
- CVS Health Corp.
- Florida Blue
- Viatris Inc.
- Aetna Inc.
- Johnson & Johnson Inc.
- Bristol-Myers Squibb Co.
- Zydus Pharmaceuticals Inc.
- Japan Tobacco
- Cipla Ltd.
- Centene Corp.
- The Kroger Co.
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 09, 2025
9th Circ. Probes Buyers On HIV Drug Antitrust Claims
Insurers and health plans told a Ninth Circuit panel on Thursday that a lower court was wrong to toss their claims that Gilead orchestrated a product-hop scheme for its HIV drugs ahead of trial and for not seeing a price drop as evidence of an alleged agreement with Teva to delay generics.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login